Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2010672 | 1.00 | MGLL (0.33) | MGLL | |
| SCHEMBL996580 | 0.96 | — | — | |
| SCHEMBL2161411 | 0.87 | — | — | |
| SCHEMBL4709193 | 0.82 | CA2 (0.41) | — | |
| Acetic Acid SCHEMBL4105219 | 0.80 | FFAR3 (0.37) | — | |
| SCHEMBL10977989 | 0.76 | — | — | |
| Propanol SCHEMBL11572118 | 0.73 | L3MBTL1 (0.31) | — | |
| SCHEMBL2249236 | 0.69 | — | — | |
| SCHEMBL442895 | 0.69 | — | — | |
| SCHEMBL14589063 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240270720-A1 | INDAZOLE YL BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2024-08-15 | — | — | US | claimed |
| CN-114805361-B | Amino substituted aromatic heterocyclic pyrazole compound, preparation method and application | 上海凌达生物医药有限公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2023139322-A1 | HYDROSILYLATION PROCESS PHOTOCATALYSED BY A MANGANESE COMPLEX | ELKEM SILICONES FRANCE SAS (FR) | 2023-07-27 | — | — | WO | claimed |
| WO-2023287128-A1 | INDAZOLE YL BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF | 한양대학교 에리카산학협력단 | 2023-01-19 | — | — | WO | claimed |
| CN-114805361-A | Amino-substituted aromatic heterocyclic pyrazole compounds, preparation method and application | 上海凌达生物医药有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114591319-A | Tetrahydropyridopyrimidine derivative and application thereof | 江苏先声药业有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-110724331-B | Polyethylene composition suitable for high-speed processing for cable sheath and preparation method thereof | 中国石油化工股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-110724334-B | Heat-resistant polyethylene composition with excellent slow crack growth resistance and preparation method thereof | 中国石油化工股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-110724332-B | Polyethylene composition with excellent comprehensive performance for double-wall corrugated pipe and preparation method thereof | 中国石油化工股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| EP-2935286-B1 | HYDROSILYLATION METHOD | ELKEM SILICONES FRANCE SAS (FR) | 2018-08-01 | — | — | EP | claimed |
| US-20040102479-A1 | Novel benzopyran or thiobenzopyran derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA | 2004-05-27 | — | — | US | claimed |
| US-6645951-B1 | Antiestrogens for treating breast cancer | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-11-11 | — | — | US | claimed |
| EP-1087959-A1 | NOVEL BENZOPYRAN OR THIOBENZOPYRAN DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-04-04 | — | — | EP | claimed |
| WO-1999065893-A1 | NOVEL BENZOPYRAN OR THIOBENZOPYRAN DERIVATIVES | C & C RESEARCH LABORATORIES (KR) | 1999-12-23 | — | — | WO | claimed |
| CN-1212625-A | Caffeine and clemastine for the treatment of respiratory diseases | PROCTER & GAMBLE (US) | 1999-03-31 | — | — | CN | claimed |
| EP-0886520-A1 | CAFFEINE AND CLEMASTINE FOR TREATING RESPIRATORY DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0841947-A1 | COMPOSITIONS CONTAINING ANALGESICS AND ANTIHISTAMINES AND METHODS FOR TREATING RESPIRATORY DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | claimed |
| WO-1997032586-A1 | CAFFEINE AND CLEMASTINE FOR TREATING RESPIRATORY DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-12 | — | — | WO | claimed |
| US-5648358-A | CAFFEINE AND PYRROLIDINE OR PIPERIDINE ETHER ANTIHISTAMINE | PROCTER & GAMBLE COMPANY, THE | 1997-07-15 | — | — | US | claimed |
| WO-1997004808-A1 | COMPOSITIONS CONTAINING ANALGESICS AND ANTIHISTAMINES AND METHODS FOR TREATING RESPIRATORY DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102479-A1 | Novel benzopyran or thiobenzopyran derivatives | NR5A1, SHBG, ESR2 | MGLL 4602/4885 |
| US-20240270720-A1 | INDAZOLE YL BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF | FLT3, JAK2, JAK3 | MGLL 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.